The global market for Tenofovir Disoproxil Fumarate API is estimated to increase from US$ million in 2021 to reach US$ million by 2028, exhibiting a CAGR of % during 2022-2028. Keeping in mind the uncertainties of COVID-19 and Russia-Ukraine War, we are continuously tracking and evaluating the direct as well as the indirect influence of the pandemic on different end use sectors. These insights are included in the report as a major market contributor.
The APAC Tenofovir Disoproxil Fumarate API market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
The United States Tenofovir Disoproxil Fumarate API market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
The Europe Tenofovir Disoproxil Fumarate API market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
The China Tenofovir Disoproxil Fumarate API market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
Global key Tenofovir Disoproxil Fumarate API players cover Mangalam Drugs & Organics Ltd, Jai Radhe Sales, NEWEDGE Overseas, Summit Pharmaceuticals Europe Srl and Zeon Health Industries, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
Report Coverage
This latest report provides a deep insight into the global Tenofovir Disoproxil Fumarate API market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, value chain analysis, etc.
This report aims to provide a comprehensive picture of the global Tenofovir Disoproxil Fumarate API market, with both quantitative and qualitative data, to help readers understand how the Tenofovir Disoproxil Fumarate API market scenario changed across the globe during the pandemic and Russia-Ukraine War.
The base year considered for analyses is 2021, while the market estimates and forecasts are given from 2022 to 2028. The market estimates are provided in terms of revenue in USD millions and volume in Kg.
Market Segmentation:
The study segments the Tenofovir Disoproxil Fumarate API market and forecasts the market size by Purity (Above 98 % and Above 99 %,), by Application (Tablets and Others.), and region (APAC, Americas, Europe, and Middle East & Africa).
Segmentation by purity
Above 98 %
Above 99 %
Segmentation by application
Tablets
Others
Segmentation by region
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
Major companies covered
Mangalam Drugs & Organics Ltd
Jai Radhe Sales
NEWEDGE Overseas
Summit Pharmaceuticals Europe Srl
Zeon Health Industries
Gonane Pharma
Aurisco Pharmaceutical Co.,Ltd
Tyche Industries Ltd
Styrax
Shanghai Desano Bio-Pharmaceutical
Zhejiang Supor Pharmaceuticals
Hetero Drugs
Lupin Ltd
Emcure Pharmaceuticals
Acebright India Pharma Private Limited
Chromo Laboratories
Blanver
Hana Pharm
Nortec Quimica
Mylan
Chapter Introduction
Chapter 1: Scope of Tenofovir Disoproxil Fumarate API, Research Methodology, etc.
Chapter 2: Executive Summary, global Tenofovir Disoproxil Fumarate API market size (sales and revenue) and CAGR, Tenofovir Disoproxil Fumarate API market size by region, by purity, by application, historical data from 2017 to 2022, and forecast to 2028.
Chapter 3: Tenofovir Disoproxil Fumarate API sales, revenue, average price, global market share, and industry ranking by company, 2017-2022
Chapter 4: Global Tenofovir Disoproxil Fumarate API sales and revenue by region and by country. Country specific data and market value analysis for the U.S., Canada, Europe, China, Japan, South Korea, Southeast Asia, India, Latin America and Middle East & Africa.
Chapter 5, 6, 7, 8: Americas, APAC, Europe, Middle East & Africa, sales segment by country, by purity, and purity.
Chapter 9: Analysis of the current market trends, market forecast, opportunities and economic trends that are affecting the future marketplace
Chapter 10: Manufacturing cost structure analysis
Chapter 11: Sales channel, distributors, and customers
Chapter 12: Global Tenofovir Disoproxil Fumarate API market size forecast by region, by country, by purity, and application.
Chapter 13: Comprehensive company profiles of the leading players, including Mangalam Drugs & Organics Ltd, Jai Radhe Sales, NEWEDGE Overseas, Summit Pharmaceuticals Europe Srl, Zeon Health Industries, Gonane Pharma, Aurisco Pharmaceutical Co.,Ltd, Tyche Industries Ltd and Styrax, etc.
Chapter 14: Research Findings and Conclusion
Table of Contents
1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Tenofovir Disoproxil Fumarate API Annual Sales 2017-2028
2.1.2 World Current & Future Analysis for Tenofovir Disoproxil Fumarate API by Geographic Region, 2017, 2022 & 2028
2.1.3 World Current & Future Analysis for Tenofovir Disoproxil Fumarate API by Country/Region, 2017, 2022 & 2028
2.2 Tenofovir Disoproxil Fumarate API Segment by Purity
2.2.1 Above 98 %
2.2.2 Above 99 %
2.3 Tenofovir Disoproxil Fumarate API Sales by Purity
2.3.1 Global Tenofovir Disoproxil Fumarate API Sales Market Share by Purity (2017-2022)
2.3.2 Global Tenofovir Disoproxil Fumarate API Revenue and Market Share by Purity (2017-2022)
2.3.3 Global Tenofovir Disoproxil Fumarate API Sale Price by Purity (2017-2022)
2.4 Tenofovir Disoproxil Fumarate API Segment by Application
2.4.1 Tablets
2.4.2 Others
2.5 Tenofovir Disoproxil Fumarate API Sales by Application
2.5.1 Global Tenofovir Disoproxil Fumarate API Sale Market Share by Application (2017-2022)
2.5.2 Global Tenofovir Disoproxil Fumarate API Revenue and Market Share by Application (2017-2022)
2.5.3 Global Tenofovir Disoproxil Fumarate API Sale Price by Application (2017-2022)
3 Global Tenofovir Disoproxil Fumarate API by Company
3.1 Global Tenofovir Disoproxil Fumarate API Breakdown Data by Company
3.1.1 Global Tenofovir Disoproxil Fumarate API Annual Sales by Company (2020-2022)
3.1.2 Global Tenofovir Disoproxil Fumarate API Sales Market Share by Company (2020-2022)
3.2 Global Tenofovir Disoproxil Fumarate API Annual Revenue by Company (2020-2022)
3.2.1 Global Tenofovir Disoproxil Fumarate API Revenue by Company (2020-2022)
3.2.2 Global Tenofovir Disoproxil Fumarate API Revenue Market Share by Company (2020-2022)
3.3 Global Tenofovir Disoproxil Fumarate API Sale Price by Company
3.4 Key Manufacturers Tenofovir Disoproxil Fumarate API Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Tenofovir Disoproxil Fumarate API Product Location Distribution
3.4.2 Players Tenofovir Disoproxil Fumarate API Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for Tenofovir Disoproxil Fumarate API by Geographic Region
4.1 World Historic Tenofovir Disoproxil Fumarate API Market Size by Geographic Region (2017-2022)
4.1.1 Global Tenofovir Disoproxil Fumarate API Annual Sales by Geographic Region (2017-2022)
4.1.2 Global Tenofovir Disoproxil Fumarate API Annual Revenue by Geographic Region
4.2 World Historic Tenofovir Disoproxil Fumarate API Market Size by Country/Region (2017-2022)
4.2.1 Global Tenofovir Disoproxil Fumarate API Annual Sales by Country/Region (2017-2022)
4.2.2 Global Tenofovir Disoproxil Fumarate API Annual Revenue by Country/Region
4.3 Americas Tenofovir Disoproxil Fumarate API Sales Growth
4.4 APAC Tenofovir Disoproxil Fumarate API Sales Growth
4.5 Europe Tenofovir Disoproxil Fumarate API Sales Growth
4.6 Middle East & Africa Tenofovir Disoproxil Fumarate API Sales Growth
5 Americas
5.1 Americas Tenofovir Disoproxil Fumarate API Sales by Country
5.1.1 Americas Tenofovir Disoproxil Fumarate API Sales by Country (2017-2022)
5.1.2 Americas Tenofovir Disoproxil Fumarate API Revenue by Country (2017-2022)
5.2 Americas Tenofovir Disoproxil Fumarate API Sales by Purity
5.3 Americas Tenofovir Disoproxil Fumarate API Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Tenofovir Disoproxil Fumarate API Sales by Region
6.1.1 APAC Tenofovir Disoproxil Fumarate API Sales by Region (2017-2022)
6.1.2 APAC Tenofovir Disoproxil Fumarate API Revenue by Region (2017-2022)
6.2 APAC Tenofovir Disoproxil Fumarate API Sales by Purity
6.3 APAC Tenofovir Disoproxil Fumarate API Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Tenofovir Disoproxil Fumarate API by Country
7.1.1 Europe Tenofovir Disoproxil Fumarate API Sales by Country (2017-2022)
7.1.2 Europe Tenofovir Disoproxil Fumarate API Revenue by Country (2017-2022)
7.2 Europe Tenofovir Disoproxil Fumarate API Sales by Purity
7.3 Europe Tenofovir Disoproxil Fumarate API Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Tenofovir Disoproxil Fumarate API by Country
8.1.1 Middle East & Africa Tenofovir Disoproxil Fumarate API Sales by Country (2017-2022)
8.1.2 Middle East & Africa Tenofovir Disoproxil Fumarate API Revenue by Country (2017-2022)
8.2 Middle East & Africa Tenofovir Disoproxil Fumarate API Sales by Purity
8.3 Middle East & Africa Tenofovir Disoproxil Fumarate API Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Tenofovir Disoproxil Fumarate API
10.3 Manufacturing Process Analysis of Tenofovir Disoproxil Fumarate API
10.4 Industry Chain Structure of Tenofovir Disoproxil Fumarate API
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Tenofovir Disoproxil Fumarate API Distributors
11.3 Tenofovir Disoproxil Fumarate API Customer
12 World Forecast Review for Tenofovir Disoproxil Fumarate API by Geographic Region
12.1 Global Tenofovir Disoproxil Fumarate API Market Size Forecast by Region
12.1.1 Global Tenofovir Disoproxil Fumarate API Forecast by Region (2023-2028)
12.1.2 Global Tenofovir Disoproxil Fumarate API Annual Revenue Forecast by Region (2023-2028)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Tenofovir Disoproxil Fumarate API Forecast by Purity
12.7 Global Tenofovir Disoproxil Fumarate API Forecast by Application
13 Key Players Analysis
13.1 Mangalam Drugs & Organics Ltd
13.1.1 Mangalam Drugs & Organics Ltd Company Information
13.1.2 Mangalam Drugs & Organics Ltd Tenofovir Disoproxil Fumarate API Product Offered
13.1.3 Mangalam Drugs & Organics Ltd Tenofovir Disoproxil Fumarate API Sales, Revenue, Price and Gross Margin (2020-2022)
13.1.4 Mangalam Drugs & Organics Ltd Main Business Overview
13.1.5 Mangalam Drugs & Organics Ltd Latest Developments
13.2 Jai Radhe Sales
13.2.1 Jai Radhe Sales Company Information
13.2.2 Jai Radhe Sales Tenofovir Disoproxil Fumarate API Product Offered
13.2.3 Jai Radhe Sales Tenofovir Disoproxil Fumarate API Sales, Revenue, Price and Gross Margin (2020-2022)
13.2.4 Jai Radhe Sales Main Business Overview
13.2.5 Jai Radhe Sales Latest Developments
13.3 NEWEDGE Overseas
13.3.1 NEWEDGE Overseas Company Information
13.3.2 NEWEDGE Overseas Tenofovir Disoproxil Fumarate API Product Offered
13.3.3 NEWEDGE Overseas Tenofovir Disoproxil Fumarate API Sales, Revenue, Price and Gross Margin (2020-2022)
13.3.4 NEWEDGE Overseas Main Business Overview
13.3.5 NEWEDGE Overseas Latest Developments
13.4 Summit Pharmaceuticals Europe Srl
13.4.1 Summit Pharmaceuticals Europe Srl Company Information
13.4.2 Summit Pharmaceuticals Europe Srl Tenofovir Disoproxil Fumarate API Product Offered
13.4.3 Summit Pharmaceuticals Europe Srl Tenofovir Disoproxil Fumarate API Sales, Revenue, Price and Gross Margin (2020-2022)
13.4.4 Summit Pharmaceuticals Europe Srl Main Business Overview
13.4.5 Summit Pharmaceuticals Europe Srl Latest Developments
13.5 Zeon Health Industries
13.5.1 Zeon Health Industries Company Information
13.5.2 Zeon Health Industries Tenofovir Disoproxil Fumarate API Product Offered
13.5.3 Zeon Health Industries Tenofovir Disoproxil Fumarate API Sales, Revenue, Price and Gross Margin (2020-2022)
13.5.4 Zeon Health Industries Main Business Overview
13.5.5 Zeon Health Industries Latest Developments
13.6 Gonane Pharma
13.6.1 Gonane Pharma Company Information
13.6.2 Gonane Pharma Tenofovir Disoproxil Fumarate API Product Offered
13.6.3 Gonane Pharma Tenofovir Disoproxil Fumarate API Sales, Revenue, Price and Gross Margin (2020-2022)
13.6.4 Gonane Pharma Main Business Overview
13.6.5 Gonane Pharma Latest Developments
13.7 Aurisco Pharmaceutical Co.,Ltd
13.7.1 Aurisco Pharmaceutical Co.,Ltd Company Information
13.7.2 Aurisco Pharmaceutical Co.,Ltd Tenofovir Disoproxil Fumarate API Product Offered
13.7.3 Aurisco Pharmaceutical Co.,Ltd Tenofovir Disoproxil Fumarate API Sales, Revenue, Price and Gross Margin (2020-2022)
13.7.4 Aurisco Pharmaceutical Co.,Ltd Main Business Overview
13.7.5 Aurisco Pharmaceutical Co.,Ltd Latest Developments
13.8 Tyche Industries Ltd
13.8.1 Tyche Industries Ltd Company Information
13.8.2 Tyche Industries Ltd Tenofovir Disoproxil Fumarate API Product Offered
13.8.3 Tyche Industries Ltd Tenofovir Disoproxil Fumarate API Sales, Revenue, Price and Gross Margin (2020-2022)
13.8.4 Tyche Industries Ltd Main Business Overview
13.8.5 Tyche Industries Ltd Latest Developments
13.9 Styrax
13.9.1 Styrax Company Information
13.9.2 Styrax Tenofovir Disoproxil Fumarate API Product Offered
13.9.3 Styrax Tenofovir Disoproxil Fumarate API Sales, Revenue, Price and Gross Margin (2020-2022)
13.9.4 Styrax Main Business Overview
13.9.5 Styrax Latest Developments
13.10 Shanghai Desano Bio-Pharmaceutical
13.10.1 Shanghai Desano Bio-Pharmaceutical Company Information
13.10.2 Shanghai Desano Bio-Pharmaceutical Tenofovir Disoproxil Fumarate API Product Offered
13.10.3 Shanghai Desano Bio-Pharmaceutical Tenofovir Disoproxil Fumarate API Sales, Revenue, Price and Gross Margin (2020-2022)
13.10.4 Shanghai Desano Bio-Pharmaceutical Main Business Overview
13.10.5 Shanghai Desano Bio-Pharmaceutical Latest Developments
13.11 Zhejiang Supor Pharmaceuticals
13.11.1 Zhejiang Supor Pharmaceuticals Company Information
13.11.2 Zhejiang Supor Pharmaceuticals Tenofovir Disoproxil Fumarate API Product Offered
13.11.3 Zhejiang Supor Pharmaceuticals Tenofovir Disoproxil Fumarate API Sales, Revenue, Price and Gross Margin (2020-2022)
13.11.4 Zhejiang Supor Pharmaceuticals Main Business Overview
13.11.5 Zhejiang Supor Pharmaceuticals Latest Developments
13.12 Hetero Drugs
13.12.1 Hetero Drugs Company Information
13.12.2 Hetero Drugs Tenofovir Disoproxil Fumarate API Product Offered
13.12.3 Hetero Drugs Tenofovir Disoproxil Fumarate API Sales, Revenue, Price and Gross Margin (2020-2022)
13.12.4 Hetero Drugs Main Business Overview
13.12.5 Hetero Drugs Latest Developments
13.13 Lupin Ltd
13.13.1 Lupin Ltd Company Information
13.13.2 Lupin Ltd Tenofovir Disoproxil Fumarate API Product Offered
13.13.3 Lupin Ltd Tenofovir Disoproxil Fumarate API Sales, Revenue, Price and Gross Margin (2020-2022)
13.13.4 Lupin Ltd Main Business Overview
13.13.5 Lupin Ltd Latest Developments
13.14 Emcure Pharmaceuticals
13.14.1 Emcure Pharmaceuticals Company Information
13.14.2 Emcure Pharmaceuticals Tenofovir Disoproxil Fumarate API Product Offered
13.14.3 Emcure Pharmaceuticals Tenofovir Disoproxil Fumarate API Sales, Revenue, Price and Gross Margin (2020-2022)
13.14.4 Emcure Pharmaceuticals Main Business Overview
13.14.5 Emcure Pharmaceuticals Latest Developments
13.15 Acebright India Pharma Private Limited
13.15.1 Acebright India Pharma Private Limited Company Information
13.15.2 Acebright India Pharma Private Limited Tenofovir Disoproxil Fumarate API Product Offered
13.15.3 Acebright India Pharma Private Limited Tenofovir Disoproxil Fumarate API Sales, Revenue, Price and Gross Margin (2020-2022)
13.15.4 Acebright India Pharma Private Limited Main Business Overview
13.15.5 Acebright India Pharma Private Limited Latest Developments
13.16 Chromo Laboratories
13.16.1 Chromo Laboratories Company Information
13.16.2 Chromo Laboratories Tenofovir Disoproxil Fumarate API Product Offered
13.16.3 Chromo Laboratories Tenofovir Disoproxil Fumarate API Sales, Revenue, Price and Gross Margin (2020-2022)
13.16.4 Chromo Laboratories Main Business Overview
13.16.5 Chromo Laboratories Latest Developments
13.17 Blanver
13.17.1 Blanver Company Information
13.17.2 Blanver Tenofovir Disoproxil Fumarate API Product Offered
13.17.3 Blanver Tenofovir Disoproxil Fumarate API Sales, Revenue, Price and Gross Margin (2020-2022)
13.17.4 Blanver Main Business Overview
13.17.5 Blanver Latest Developments
13.18 Hana Pharm
13.18.1 Hana Pharm Company Information
13.18.2 Hana Pharm Tenofovir Disoproxil Fumarate API Product Offered
13.18.3 Hana Pharm Tenofovir Disoproxil Fumarate API Sales, Revenue, Price and Gross Margin (2020-2022)
13.18.4 Hana Pharm Main Business Overview
13.18.5 Hana Pharm Latest Developments
13.19 Nortec Quimica
13.19.1 Nortec Quimica Company Information
13.19.2 Nortec Quimica Tenofovir Disoproxil Fumarate API Product Offered
13.19.3 Nortec Quimica Tenofovir Disoproxil Fumarate API Sales, Revenue, Price and Gross Margin (2020-2022)
13.19.4 Nortec Quimica Main Business Overview
13.19.5 Nortec Quimica Latest Developments
13.20 Mylan
13.20.1 Mylan Company Information
13.20.2 Mylan Tenofovir Disoproxil Fumarate API Product Offered
13.20.3 Mylan Tenofovir Disoproxil Fumarate API Sales, Revenue, Price and Gross Margin (2020-2022)
13.20.4 Mylan Main Business Overview
13.20.5 Mylan Latest Developments
14 Research Findings and Conclusion
List of Tables
Table 1. Tenofovir Disoproxil Fumarate API Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)
Table 2. Tenofovir Disoproxil Fumarate API Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)
Table 3. Major Players of Above 98 %
Table 4. Major Players of Above 99 %
Table 5. Global Tenofovir Disoproxil Fumarate API Sales by Purity (2017-2022) & (Kg)
Table 6. Global Tenofovir Disoproxil Fumarate API Sales Market Share by Purity (2017-2022)
Table 7. Global Tenofovir Disoproxil Fumarate API Revenue by Purity (2017-2022) & ($ million)
Table 8. Global Tenofovir Disoproxil Fumarate API Revenue Market Share by Purity (2017-2022)
Table 9. Global Tenofovir Disoproxil Fumarate API Sale Price by Purity (2017-2022) & (US$/Kg)
Table 10. Global Tenofovir Disoproxil Fumarate API Sales by Application (2017-2022) & (Kg)
Table 11. Global Tenofovir Disoproxil Fumarate API Sales Market Share by Application (2017-2022)
Table 12. Global Tenofovir Disoproxil Fumarate API Revenue by Application (2017-2022)
Table 13. Global Tenofovir Disoproxil Fumarate API Revenue Market Share by Application (2017-2022)
Table 14. Global Tenofovir Disoproxil Fumarate API Sale Price by Application (2017-2022) & (US$/Kg)
Table 15. Global Tenofovir Disoproxil Fumarate API Sales by Company (2020-2022) & (Kg)
Table 16. Global Tenofovir Disoproxil Fumarate API Sales Market Share by Company (2020-2022)
Table 17. Global Tenofovir Disoproxil Fumarate API Revenue by Company (2020-2022) ($ Millions)
Table 18. Global Tenofovir Disoproxil Fumarate API Revenue Market Share by Company (2020-2022)
Table 19. Global Tenofovir Disoproxil Fumarate API Sale Price by Company (2020-2022) & (US$/Kg)
Table 20. Key Manufacturers Tenofovir Disoproxil Fumarate API Producing Area Distribution and Sales Area
Table 21. Players Tenofovir Disoproxil Fumarate API Products Offered
Table 22. Tenofovir Disoproxil Fumarate API Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
Table 23. New Products and Potential Entrants
Table 24. Mergers & Acquisitions, Expansion
Table 25. Global Tenofovir Disoproxil Fumarate API Sales by Geographic Region (2017-2022) & (Kg)
Table 26. Global Tenofovir Disoproxil Fumarate API Sales Market Share Geographic Region (2017-2022)
Table 27. Global Tenofovir Disoproxil Fumarate API Revenue by Geographic Region (2017-2022) & ($ millions)
Table 28. Global Tenofovir Disoproxil Fumarate API Revenue Market Share by Geographic Region (2017-2022)
Table 29. Global Tenofovir Disoproxil Fumarate API Sales by Country/Region (2017-2022) & (Kg)
Table 30. Global Tenofovir Disoproxil Fumarate API Sales Market Share by Country/Region (2017-2022)
Table 31. Global Tenofovir Disoproxil Fumarate API Revenue by Country/Region (2017-2022) & ($ millions)
Table 32. Global Tenofovir Disoproxil Fumarate API Revenue Market Share by Country/Region (2017-2022)
Table 33. Americas Tenofovir Disoproxil Fumarate API Sales by Country (2017-2022) & (Kg)
Table 34. Americas Tenofovir Disoproxil Fumarate API Sales Market Share by Country (2017-2022)
Table 35. Americas Tenofovir Disoproxil Fumarate API Revenue by Country (2017-2022) & ($ Millions)
Table 36. Americas Tenofovir Disoproxil Fumarate API Revenue Market Share by Country (2017-2022)
Table 37. Americas Tenofovir Disoproxil Fumarate API Sales by Type (2017-2022) & (Kg)
Table 38. Americas Tenofovir Disoproxil Fumarate API Sales Market Share by Purity (2017-2022)
Table 39. Americas Tenofovir Disoproxil Fumarate API Sales by Application (2017-2022) & (Kg)
Table 40. Americas Tenofovir Disoproxil Fumarate API Sales Market Share by Application (2017-2022)
Table 41. APAC Tenofovir Disoproxil Fumarate API Sales by Region (2017-2022) & (Kg)
Table 42. APAC Tenofovir Disoproxil Fumarate API Sales Market Share by Region (2017-2022)
Table 43. APAC Tenofovir Disoproxil Fumarate API Revenue by Region (2017-2022) & ($ Millions)
Table 44. APAC Tenofovir Disoproxil Fumarate API Revenue Market Share by Region (2017-2022)
Table 45. APAC Tenofovir Disoproxil Fumarate API Sales by Purity (2017-2022) & (Kg)
Table 46. APAC Tenofovir Disoproxil Fumarate API Sales Market Share by Purity (2017-2022)
Table 47. APAC Tenofovir Disoproxil Fumarate API Sales by Application (2017-2022) & (Kg)
Table 48. APAC Tenofovir Disoproxil Fumarate API Sales Market Share by Application (2017-2022)
Table 49. Europe Tenofovir Disoproxil Fumarate API Sales by Country (2017-2022) & (Kg)
Table 50. Europe Tenofovir Disoproxil Fumarate API Sales Market Share by Country (2017-2022)
Table 51. Europe Tenofovir Disoproxil Fumarate API Revenue by Country (2017-2022) & ($ Millions)
Table 52. Europe Tenofovir Disoproxil Fumarate API Revenue Market Share by Country (2017-2022)
Table 53. Europe Tenofovir Disoproxil Fumarate API Sales by Type (2017-2022) & (Kg)
Table 54. Europe Tenofovir Disoproxil Fumarate API Sales Market Share by Purity (2017-2022)
Table 55. Europe Tenofovir Disoproxil Fumarate API Sales by Application (2017-2022) & (Kg)
Table 56. Europe Tenofovir Disoproxil Fumarate API Sales Market Share by Application (2017-2022)
Table 57. Middle East & Africa Tenofovir Disoproxil Fumarate API Sales by Country (2017-2022) & (Kg)
Table 58. Middle East & Africa Tenofovir Disoproxil Fumarate API Sales Market Share by Country (2017-2022)
Table 59. Middle East & Africa Tenofovir Disoproxil Fumarate API Revenue by Country (2017-2022) & ($ Millions)
Table 60. Middle East & Africa Tenofovir Disoproxil Fumarate API Revenue Market Share by Country (2017-2022)
Table 61. Middle East & Africa Tenofovir Disoproxil Fumarate API Sales by Purity (2017-2022) & (Kg)
Table 62. Middle East & Africa Tenofovir Disoproxil Fumarate API Sales Market Share by Purity (2017-2022)
Table 63. Middle East & Africa Tenofovir Disoproxil Fumarate API Sales by Application (2017-2022) & (Kg)
Table 64. Middle East & Africa Tenofovir Disoproxil Fumarate API Sales Market Share by Application (2017-2022)
Table 65. Key Market Drivers & Growth Opportunities of Tenofovir Disoproxil Fumarate API
Table 66. Key Market Challenges & Risks of Tenofovir Disoproxil Fumarate API
Table 67. Key Industry Trends of Tenofovir Disoproxil Fumarate API
Table 68. Tenofovir Disoproxil Fumarate API Raw Material
Table 69. Key Suppliers of Raw Materials
Table 70. Tenofovir Disoproxil Fumarate API Distributors List
Table 71. Tenofovir Disoproxil Fumarate API Customer List
Table 72. Global Tenofovir Disoproxil Fumarate API Sales Forecast by Region (2023-2028) & (Kg)
Table 73. Global Tenofovir Disoproxil Fumarate API Sales Market Forecast by Region
Table 74. Global Tenofovir Disoproxil Fumarate API Revenue Forecast by Region (2023-2028) & ($ millions)
Table 75. Global Tenofovir Disoproxil Fumarate API Revenue Market Share Forecast by Region (2023-2028)
Table 76. Americas Tenofovir Disoproxil Fumarate API Sales Forecast by Country (2023-2028) & (Kg)
Table 77. Americas Tenofovir Disoproxil Fumarate API Revenue Forecast by Country (2023-2028) & ($ millions)
Table 78. APAC Tenofovir Disoproxil Fumarate API Sales Forecast by Region (2023-2028) & (Kg)
Table 79. APAC Tenofovir Disoproxil Fumarate API Revenue Forecast by Region (2023-2028) & ($ millions)
Table 80. Europe Tenofovir Disoproxil Fumarate API Sales Forecast by Country (2023-2028) & (Kg)
Table 81. Europe Tenofovir Disoproxil Fumarate API Revenue Forecast by Country (2023-2028) & ($ millions)
Table 82. Middle East & Africa Tenofovir Disoproxil Fumarate API Sales Forecast by Country (2023-2028) & (Kg)
Table 83. Middle East & Africa Tenofovir Disoproxil Fumarate API Revenue Forecast by Country (2023-2028) & ($ millions)
Table 84. Global Tenofovir Disoproxil Fumarate API Sales Forecast by Purity (2023-2028) & (Kg)
Table 85. Global Tenofovir Disoproxil Fumarate API Sales Market Share Forecast by Purity (2023-2028)
Table 86. Global Tenofovir Disoproxil Fumarate API Revenue Forecast by Purity (2023-2028) & ($ Millions)
Table 87. Global Tenofovir Disoproxil Fumarate API Revenue Market Share Forecast by Purity (2023-2028)
Table 88. Global Tenofovir Disoproxil Fumarate API Sales Forecast by Application (2023-2028) & (Kg)
Table 89. Global Tenofovir Disoproxil Fumarate API Sales Market Share Forecast by Application (2023-2028)
Table 90. Global Tenofovir Disoproxil Fumarate API Revenue Forecast by Application (2023-2028) & ($ Millions)
Table 91. Global Tenofovir Disoproxil Fumarate API Revenue Market Share Forecast by Application (2023-2028)
Table 92. Mangalam Drugs & Organics Ltd Basic Information, Tenofovir Disoproxil Fumarate API Manufacturing Base, Sales Area and Its Competitors
Table 93. Mangalam Drugs & Organics Ltd Tenofovir Disoproxil Fumarate API Product Offered
Table 94. Mangalam Drugs & Organics Ltd Tenofovir Disoproxil Fumarate API Sales (Kg), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2020-2022)
Table 95. Mangalam Drugs & Organics Ltd Main Business
Table 96. Mangalam Drugs & Organics Ltd Latest Developments
Table 97. Jai Radhe Sales Basic Information, Tenofovir Disoproxil Fumarate API Manufacturing Base, Sales Area and Its Competitors
Table 98. Jai Radhe Sales Tenofovir Disoproxil Fumarate API Product Offered
Table 99. Jai Radhe Sales Tenofovir Disoproxil Fumarate API Sales (Kg), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2020-2022)
Table 100. Jai Radhe Sales Main Business
Table 101. Jai Radhe Sales Latest Developments
Table 102. NEWEDGE Overseas Basic Information, Tenofovir Disoproxil Fumarate API Manufacturing Base, Sales Area and Its Competitors
Table 103. NEWEDGE Overseas Tenofovir Disoproxil Fumarate API Product Offered
Table 104. NEWEDGE Overseas Tenofovir Disoproxil Fumarate API Sales (Kg), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2020-2022)
Table 105. NEWEDGE Overseas Main Business
Table 106. NEWEDGE Overseas Latest Developments
Table 107. Summit Pharmaceuticals Europe Srl Basic Information, Tenofovir Disoproxil Fumarate API Manufacturing Base, Sales Area and Its Competitors
Table 108. Summit Pharmaceuticals Europe Srl Tenofovir Disoproxil Fumarate API Product Offered
Table 109. Summit Pharmaceuticals Europe Srl Tenofovir Disoproxil Fumarate API Sales (Kg), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2020-2022)
Table 110. Summit Pharmaceuticals Europe Srl Main Business
Table 111. Summit Pharmaceuticals Europe Srl Latest Developments
Table 112. Zeon Health Industries Basic Information, Tenofovir Disoproxil Fumarate API Manufacturing Base, Sales Area and Its Competitors
Table 113. Zeon Health Industries Tenofovir Disoproxil Fumarate API Product Offered
Table 114. Zeon Health Industries Tenofovir Disoproxil Fumarate API Sales (Kg), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2020-2022)
Table 115. Zeon Health Industries Main Business
Table 116. Zeon Health Industries Latest Developments
Table 117. Gonane Pharma Basic Information, Tenofovir Disoproxil Fumarate API Manufacturing Base, Sales Area and Its Competitors
Table 118. Gonane Pharma Tenofovir Disoproxil Fumarate API Product Offered
Table 119. Gonane Pharma Tenofovir Disoproxil Fumarate API Sales (Kg), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2020-2022)
Table 120. Gonane Pharma Main Business
Table 121. Gonane Pharma Latest Developments
Table 122. Aurisco Pharmaceutical Co.,Ltd Basic Information, Tenofovir Disoproxil Fumarate API Manufacturing Base, Sales Area and Its Competitors
Table 123. Aurisco Pharmaceutical Co.,Ltd Tenofovir Disoproxil Fumarate API Product Offered
Table 124. Aurisco Pharmaceutical Co.,Ltd Tenofovir Disoproxil Fumarate API Sales (Kg), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2020-2022)
Table 125. Aurisco Pharmaceutical Co.,Ltd Main Business
Table 126. Aurisco Pharmaceutical Co.,Ltd Latest Developments
Table 127. Tyche Industries Ltd Basic Information, Tenofovir Disoproxil Fumarate API Manufacturing Base, Sales Area and Its Competitors
Table 128. Tyche Industries Ltd Tenofovir Disoproxil Fumarate API Product Offered
Table 129. Tyche Industries Ltd Tenofovir Disoproxil Fumarate API Sales (Kg), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2020-2022)
Table 130. Tyche Industries Ltd Main Business
Table 131. Tyche Industries Ltd Latest Developments
Table 132. Styrax Basic Information, Tenofovir Disoproxil Fumarate API Manufacturing Base, Sales Area and Its Competitors
Table 133. Styrax Tenofovir Disoproxil Fumarate API Product Offered
Table 134. Styrax Tenofovir Disoproxil Fumarate API Sales (Kg), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2020-2022)
Table 135. Styrax Main Business
Table 136. Styrax Latest Developments
Table 137. Shanghai Desano Bio-Pharmaceutical Basic Information, Tenofovir Disoproxil Fumarate API Manufacturing Base, Sales Area and Its Competitors
Table 138. Shanghai Desano Bio-Pharmaceutical Tenofovir Disoproxil Fumarate API Product Offered
Table 139. Shanghai Desano Bio-Pharmaceutical Tenofovir Disoproxil Fumarate API Sales (Kg), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2020-2022)
Table 140. Shanghai Desano Bio-Pharmaceutical Main Business
Table 141. Shanghai Desano Bio-Pharmaceutical Latest Developments
Table 142. Zhejiang Supor Pharmaceuticals Basic Information, Tenofovir Disoproxil Fumarate API Manufacturing Base, Sales Area and Its Competitors
Table 143. Zhejiang Supor Pharmaceuticals Tenofovir Disoproxil Fumarate API Product Offered
Table 144. Zhejiang Supor Pharmaceuticals Tenofovir Disoproxil Fumarate API Sales (Kg), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2020-2022)
Table 145. Zhejiang Supor Pharmaceuticals Main Business
Table 146. Zhejiang Supor Pharmaceuticals Latest Developments
Table 147. Hetero Drugs Basic Information, Tenofovir Disoproxil Fumarate API Manufacturing Base, Sales Area and Its Competitors
Table 148. Hetero Drugs Tenofovir Disoproxil Fumarate API Product Offered
Table 149. Hetero Drugs Tenofovir Disoproxil Fumarate API Sales (Kg), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2020-2022)
Table 150. Hetero Drugs Main Business
Table 151. Hetero Drugs Latest Developments
Table 152. Lupin Ltd Basic Information, Tenofovir Disoproxil Fumarate API Manufacturing Base, Sales Area and Its Competitors
Table 153. Lupin Ltd Tenofovir Disoproxil Fumarate API Product Offered
Table 154. Lupin Ltd Tenofovir Disoproxil Fumarate API Sales (Kg), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2020-2022)
Table 155. Lupin Ltd Main Business
Table 156. Lupin Ltd Latest Developments
Table 157. Emcure Pharmaceuticals Basic Information, Tenofovir Disoproxil Fumarate API Manufacturing Base, Sales Area and Its Competitors
Table 158. Emcure Pharmaceuticals Tenofovir Disoproxil Fumarate API Product Offered
Table 159. Emcure Pharmaceuticals Tenofovir Disoproxil Fumarate API Sales (Kg), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2020-2022)
Table 160. Emcure Pharmaceuticals Main Business
Table 161. Emcure Pharmaceuticals Latest Developments
Table 162. Acebright India Pharma Private Limited Basic Information, Tenofovir Disoproxil Fumarate API Manufacturing Base, Sales Area and Its Competitors
Table 163. Acebright India Pharma Private Limited Tenofovir Disoproxil Fumarate API Product Offered
Table 164. Acebright India Pharma Private Limited Tenofovir Disoproxil Fumarate API Sales (Kg), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2020-2022)
Table 165. Acebright India Pharma Private Limited Main Business
Table 166. Acebright India Pharma Private Limited Latest Developments
Table 167. Chromo Laboratories Basic Information, Tenofovir Disoproxil Fumarate API Manufacturing Base, Sales Area and Its Competitors
Table 168. Chromo Laboratories Tenofovir Disoproxil Fumarate API Product Offered
Table 169. Chromo Laboratories Tenofovir Disoproxil Fumarate API Sales (Kg), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2020-2022)
Table 170. Chromo Laboratories Main Business
Table 171. Chromo Laboratories Latest Developments
Table 172. Blanver Basic Information, Tenofovir Disoproxil Fumarate API Manufacturing Base, Sales Area and Its Competitors
Table 173. Blanver Tenofovir Disoproxil Fumarate API Product Offered
Table 174. Blanver Tenofovir Disoproxil Fumarate API Sales (Kg), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2020-2022)
Table 175. Blanver Main Business
Table 176. Blanver Latest Developments
Table 177. Hana Pharm Basic Information, Tenofovir Disoproxil Fumarate API Manufacturing Base, Sales Area and Its Competitors
Table 178. Hana Pharm Tenofovir Disoproxil Fumarate API Product Offered
Table 179. Hana Pharm Tenofovir Disoproxil Fumarate API Sales (Kg), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2020-2022)
Table 180. Hana Pharm Main Business
Table 181. Hana Pharm Latest Developments
Table 182. Nortec Quimica Basic Information, Tenofovir Disoproxil Fumarate API Manufacturing Base, Sales Area and Its Competitors
Table 183. Nortec Quimica Tenofovir Disoproxil Fumarate API Product Offered
Table 184. Nortec Quimica Tenofovir Disoproxil Fumarate API Sales (Kg), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2020-2022)
Table 185. Nortec Quimica Main Business
Table 186. Nortec Quimica Latest Developments
Table 187. Mylan Basic Information, Tenofovir Disoproxil Fumarate API Manufacturing Base, Sales Area and Its Competitors
Table 188. Mylan Tenofovir Disoproxil Fumarate API Product Offered
Table 189. Mylan Tenofovir Disoproxil Fumarate API Sales (Kg), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2020-2022)
Table 190. Mylan Main Business
Table 191. Mylan Latest Developments
List of Figures
Figure 1. Picture of Tenofovir Disoproxil Fumarate API
Figure 2. Tenofovir Disoproxil Fumarate API Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Tenofovir Disoproxil Fumarate API Sales Growth Rate 2017-2028 (Kg)
Figure 7. Global Tenofovir Disoproxil Fumarate API Revenue Growth Rate 2017-2028 ($ Millions)
Figure 8. Tenofovir Disoproxil Fumarate API Sales by Region (2021 & 2028) & ($ millions)
Figure 9. Product Picture of Above 98 %
Figure 10. Product Picture of Above 99 %
Figure 11. Global Tenofovir Disoproxil Fumarate API Sales Market Share by Purity in 2021
Figure 12
Global Graphitized Carbon Black (GCB) Ma..
Graphitized carbon black is a black particle that can be use..
+16467917070US (Toll Free)